Earnings

Bayer Affirms FY2026 Adj EPS Guidance of $1.20-$1.35 vs $1.27 Est; Affirms FY2026 Sales Guidance of $52.109B-$54.451B vs $52.540B Est

Nov 3, 2026 · 03:39 AM ET· updated 2h ago

Bayer (OTC:BAYRY) affirms FY2026 Adj EPS guidance from $1.20-$1.35 to $1.20-$1.35 vs $1.27 analyst estimate. Affirms FY2026 sales outlook from $52.109 billion-$54.451 billion to $52.109 billion-$54.451 billion vs

Why It Matters

Bayer stuck with its 2026 promises for profit and sales. The company feels confident about hitting the targets it already set.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

BAYRY13.95

-0.04 (-0.29%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.